| For: | Zhang KX, Kan CX, Han F, Zhang JW, Sun XD. Elucidating the cardioprotective mechanisms of sodium-glucose cotransporter-2 inhibitors beyond glycemic control. World J Diabetes 2024; 15(2): 137-141 [PMID: 38464375 DOI: 10.4239/wjd.v15.i2.137] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i2/137.htm |
| Number | Citing Articles |
| 1 |
Chenyun Wang, Minghao Li, Yulong Guo, Zheli Li, Weihu Long, Kuanchao Sun, Feiling Song, Yunguang Hu, Anguo Yin, Yuping Zhang, Jiye Yin, Qing Xia, Donghong Tang. A >8-year two-generation study on the long-term effects of genetically modified maize (Zea mays) containing cry1Ab/cry2Aj and EPSPS genes on cardiac function and arrhythmia risk of cynomolgus macaques. Food and Chemical Toxicology 2026; 211: 115990 doi: 10.1016/j.fct.2026.115990
|
| 2 |
Yi Ji, Jiaxin Zhou, Zhen Lian, Binbing Shi, Yanqing Pan, Yuan Yin, Jie Liu, Guoping Zhao, Changxi Zhang, Hong Zhu, Defeng Pan. Does diabetes affect the incidence of non-target lesion revascularization? A meta-analysis of data from randomized controlled trials. BMC Endocrine Disorders 2026; doi: 10.1186/s12902-026-02217-x
|
| 3 |
Mahmoud Abdelaziz, Mohammed Abdel Hassib, Tamer Fouad, Ibrahim F. Said, Attia M. Shokr, Abdelrahman E Metwally, Ahmed S Abdelaziz, Ahmed M Elbeny, Abdelaal A. Elkhouly , Mostafa E Soltan, Ashraf A Alamir, Mohammad Eltahlawi. Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Function and Residual Kidney Function in Haemodialysis Patients: A Three-Month Follow-Up. Cureus 2025; doi: 10.7759/cureus.95876
|
| 4 |
跃 沈. Research Progress of SGLT2 Inhibitors in Pulmonary Hypertension. Advances in Clinical Medicine 2026; 16(02): 538 doi: 10.12677/acm.2026.162423
|
| 5 |
Cahit Demirkiran, Seniz Demiryurek, Abdullah Tuncay Demiryurek. Recent Progress and Perspectives in Sodium-Glucose Co-transporter 1/2
Inhibitors. Mini-Reviews in Medicinal Chemistry 2025; 25(5): 354 doi: 10.2174/0113895575325210240805092741
|
